Tysabri Every 6 Weeks as Effective as Standard Dosing & Self-esteem And MS-related Incontinence
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Tysabri given every six weeks was found as effective as the standard dosing at stopping nervous system damage in RRMS patients. He also reads “Recovering My Self-esteem After Adapting to MS-related Incontinence”, from Beth Ullah's, regular column "Through the Looking Glass." ==================================...
11m May 16, 2022
11m
Survey Shows MS Impacts All Aspects of Life & Remembering My First MS Symptom
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how MS affects all aspects of life, from physical and mental health to relationships and hobbies, according to results from a U.K. online survey. He also reads "Remembering My First MS Symptom”, from Ed Tobias' column, "The MS Wire." =================================== Are you interested in learnin...
12m May 13, 2022
12m
PoNS Device for MS Gait Problems Available in US & MSer Bed-bound for 2 Years Can Now Walk
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about the portable neuromodulation stimulator (PoNS) device that was approved by the FDA last year to help treat multiple sclerosis gait problems. He also reads “The MSer Who Lay in Bed for 2 Years and Can Now Walk Again”, a column by John Connor. =================================== Are you interested in ...
10m May 11, 2022
10m
NfL Levels Help Predict Relapsing MS Progression & Bone Marrow Infusions and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how blood levels of neurofilament light chain (NfL) helped predict disease progression in multiple sclerosis patients in a Phase 3 trial. He also reads “MS News That Caught My Eye Last Week: Bone Marrow Infusions, ATA188, Enhanced MRIs, Costs”, a column by Ed Tobias. =============================...
13m May 09, 2022
13m
Biomarker Test Granted Breakthrough Device Status & Intermittent Catheterization With a Wheelchair
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a blood test for the multiple sclerosis biomarker, neurofilament light chain, has been granted breakthrough device designation by the FDA. He also reads “The Tricks of Intermittent Catheterization When You’re in a Wheelchair” a column by John Connor. =================================== Are you interested in ...
9m May 06, 2022
9m
Trial of Metformin-Clemastine Combo Enrolls First Patient & The High Cost of Living With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a trial will test an antihistamine in combination with the diabetes medicine metformin as a way to repair the myelin sheath. He also reads the column by Ed Tobias, The MS Wire, “The High Cost of Living With MS”. =================================== Are you interested in learning more about multiple sclerosis?...
10m May 04, 2022
10m
Active PMS Patients Safely Underwent a Repeat Bone Marrow Infusion & Plasmapheresis Experience
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how four active progressive MS patients safely underwent a second harvesting and infusion of bone marrow cells in a safety, proof-of-concept trial. He also reads “Pain and Positivity: My Experience With Plasmapheresis,” a column by Beth Ullah.
10m May 02, 2022
10m
1st RRMS Patient Dosed in Trial of Immunotherapy & MS News That Caught Ed Tobias' Attention
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a Phase 1/2 clinical trial has begun dosing with IMCY-0141, Imcyse’s targeted immunotherapy to slow progression of relapsing-remitting MS. He also reads “MS News That Caught My Eye Last Week: Deep Brain Stimulation, IMCY-0141, Foralumab, Vumerity,” a column by Ed Tobias. ====================...
11m Apr 29, 2022
11m
Jenn Powell Talks to Neurologist Dr. Brandon Beaber
Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. Dr. Beaber is also the author of Resilience in the Face of Multiple Sclerosis, where he shares examples of people who have made great strides and life pivots despite their degenerative conditions. Listen as they discuss why multiple sclero...
39m Apr 28, 2022
39m
Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-active progressive MS patients. He also reads “Upon Reflection, I’m Determined to Seize the Day” from "The MS Wire," a column by Ed Tobias. =================================== Are you interested in l...
11m Apr 27, 2022
11m
MS Patients May Meet Criteria for Sjögren’s Diagnosis & Managing a Wheelchair Mishap
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis. He also reads “‘Top Gear’: Unfortunately, I’m a Backward-leaning Jeremy Clarkson”, a column by John Connor. =================================== Are you interested in learning more about multipl...
10m Apr 25, 2022
10m
NVG-291 Trial in MS Patients Anticipated & How To Improve MS Patient-Provider Relationships
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291, an experimental therapy to promote nervous system repair, has been well-tolerated in an ongoing Phase 1 study in healthy volunteers. He also reads the latest MS News Today’s Expert Voices article. In this instalment, Annie Brewster, MD, who also has MS, shares her tips on how to improve patient-provi...
17m Apr 22, 2022
17m
Eight More Patients Cleared for Foralumab Treatment & Crossing the Lemtrada Finish Line
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a special access program. He also reads “Crossing the Lemtrada Finish Line”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If s...
12m Apr 20, 2022
12m
Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years. He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? I...
11m Apr 18, 2022
11m
CONSONANCE Update Shows Ocrevus’ Effectiveness After 1 Year & Managing UTI Admissions and More
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how 75% of SPMS and PPMS patients in the CONSONANCE trial showed no evidence of disease progression after a year of Ocrevus treatment. He also reads “Old Friends, Broken Chairs, UTI Admissions, and Redemption”, a column by John Connor. =================================== Are you interested in l...
11m Apr 15, 2022
11m
Questionnaire To Help Women Talk About Sexual Health and MS & Staying Busy With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a questionnaire tailored for women with multiple sclerosis may help them talk to their doctor about their sexual health. He also reads “The Building Blocks of Becoming a Busy Bee”, a column by Beth Ullah. =================================== Are you interested in learning more about multiple sclerosis? If so...
10m Apr 13, 2022
10m
No Link Between Herpes Infection and MS Risk & Artist Turns MRI Scans Into Art
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how infection with the herpes simplex virus does not increase the risk of multiple sclerosis, according to a new analysis based on genetic data. He also reads the news article, “Artist With MS Finds Beauty, Individuality in MRI Brain Scans”. =================================== Are you interested...
12m Apr 11, 2022
12m
National MS Society Details Pathways to Cures Roadmap & Expert Voices: Vitamin D and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the National Multiple Sclerosis Society detailed its Pathways to Cures Roadmap and ways to advance each pathway, with the goal to end MS. He also reads an article from MS News Today’s "Expert Voices", where Kassandra Munger explores research about the connection between vitamin D levels and MS, and shares her...
15m Apr 08, 2022
15m
Key to Unlocking Blood-brain Barrier Discovered & Jokes and Humor in MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how researchers have discovered the key to bypassing the blood-brain barrier, which may lead to the development of more targeted MS treatments. He also reads “Dry Glaucomflecken and Other Healthcare Jokers” from Ed Tobias' column, "The MS Wire". =================================== Are you interested in...
11m Apr 06, 2022
11m
Scientists Review State of Cannabis Research in MS & MS Wound Management
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how cannabis-based medications could ease muscle spasms, decrease pain, and aid in sleep for people with MS. He also reads “The Heel that Won’t Heal”, by John Connor, from his column "Fall Down, Get Up Again". =================================== Are you interested in learning more about multiple scl...
11m Apr 04, 2022
11m
STAT5 Protein Complex Implicated in MS Autoimmunity & One Month of MS Awareness Isn’t Enough
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how a four-protein complex of the protein STAT5 could be involved in the development of MS-like autoimmune disease in mice. He also reads “One Month of MS Awareness Isn’t Enough”, from Ed Tobias' column, "The MS Wire". =================================== Are you interested in learning more about multiple sclerosi...
9m Apr 01, 2022
9m
Jenn Powell Talks to Tim Coetzee, from the National Multiple Sclerosis Society
Tim Coetzee is the Chief Advocacy, Services and Science Officer at the National Multiple Sclerosis Society. Tim leads all efforts focused on state and federal advocacy, marketing and communications, services and connection programs. He leads staff for the International Progressive MS Alliance – a global collaboration of MS Societies, scientists, the pharmaceutical industry and people with progr...
40m Mar 31, 2022
40m
No Increased Risk Found From Ocrevus Exposure in Pregnancy & Stem Cell Transplant Gaining Ground
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found no increased risks for women with MS or their babies after exposure to Ocrevus before or during pregnancy. He also reads an article about how autologous hematopoietic stem cell transplant, despite risks, may be a viable treatment option for some MS patients. =================================== ...
21m Mar 30, 2022
21m
NervGen to Enroll 2nd Volunteer Group in NVG-291 Trial & The Invisible Symptoms of MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical trial. He also reads “The Visible and Invisible Reflections of MS”, from Beth Ullah's column "Through the Looking Glass". =================================== Are you interested in learning more about...
10m Mar 28, 2022
10m
Myelin-restoring Medication Found Safe & Finding Purpose With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how PIPE-307, a myelin-restoring treatment, was found safe in a Phase 1 clinical trial in 70 healthy adults. He also reads “31 Days of MS: My Diagnosis Helped Me Find My Purpose”, a story from our #31DaysOfMS initiative. =================================== Are you interested in learning more ab...
8m Mar 25, 2022
8m
Drinking Alcohol Daily May Speed Loss of Nerve Cells & Keto Diet and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how people with MS who drink alcohol on a daily basis may be at risk of losing nerve cells more quickly, according to a study. He also reads “MS News That Caught My Eye Last Week: Keto Diet, Milk and MS, Disability Progression, Neural Sleeve”, from Ed Tobias’ column, "The MS Wire". ===============================...
11m Mar 23, 2022
11m
Ketogenic Diet Eases Symptoms & ‘Cog Fog’, Spinal Atrophy and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how RRMS patients following a low-carb, high-fat diet for 6 months, showed better physical and mental health. He also reads “MS News That Caught My Eye Last Week: ‘Cog Fog’, Tolebrutinib, Ublituximab, Spinal Atrophy”, from Ed Tobias' column "The MS Wire". =================================== Are ...
10m Mar 21, 2022
10m
Immune Reaction to Milk Protein May Explain Link to MS & Self-discovery With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice immunized with casein showed a nervous system inflammation and demyelination and how this may explain why MS symptoms can worsen with dairy. He also reads “31 Days of MS: Living with MS Has Launched My Radical Self-discovery”, a story from our #31DaysOfMS initiative. =================================== ...
9m Mar 18, 2022
9m
Stem Cell Therapy Shows Neuroprotective Effects & Spasticity, NfL Blood Test and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how administering NG-01 stem cell therapy directly into the spinal canal of patients with active progressive MS, reduced NfL levels. Price also reads “MS News That Caught My Eye Last Week: aHSCT, Skin Cancer, Spasticity, NfL Blood Test”, from Ed Tobias' column, "The MS Wire". =================================== Ar...
15m Mar 16, 2022
15m
Masitinib Slows Disability Progression, A Daughter's Diagnosis & Finding Strength With a New Mindset
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Masitinib significantly slows disability progression in adults with PPMS and non-active SPMS, according to new data. He also reads the news article, “31 Days of MS: My Daughter’s Diagnosis Has Brought Us Closer” and “31 Days of MS: A New Mindset Made Me Stronger”. Check out other ’31 Days of MS’ stories here....
14m Mar 14, 2022
14m
Mavenclad Works Best at Reducing Relapses & Managing Fatigue Through Medication
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, covers how MS patients on Mavenclad are less likely to experience a disease relapse than those on other oral DMTs like Gilenya, Tecfidera, or Aubagio. He also reads “The Double-Edged Sword of Fatigue Medications”, from Beth Ullah's column "Through the Looking Glass". =================================== Are you interested...
12m Mar 11, 2022
12m
Immune System ‘Reset’ by Stem Cell Transplant & Managing Anal Catheter Mishaps
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a stem cell transplant can reduce relapse rates and ease disability in MS patients, especially those with milder symptoms. He also reads “The Captain and His No. 2”, from John Connor's regular column "Fall Down, Get Up Again". =================================== Are you interested in learnin...
10m Mar 09, 2022
10m
Greater Cancer Risk Linked to Certain Oral DMTs & Supplements for MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how S1P receptor modulators such as Mayzent and Gilenya may be associated with a greater likelihood of skin cancer. He also reads “The Supplements of Mice and Men”, from John Connor's regular column "Fall Down, Get Up Again". =================================== Are you interested in learning mor...
12m Mar 07, 2022
12m
NfL Blood Test May Help Predict MS Activity & Heat Sensitivity and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how levels of neurofilament light chain (NfL) in the blood can be used to predict the risk of future disease activity in people with MS. He also reads “The Furious Fire of Heat Sensitivity”, from Beth Ullah's column Through the Looking Glass. =================================== Are you interested in learning more ...
11m Mar 04, 2022
11m
Cognitive Problems May Be Due to Myelin Loss & Neurodynamic Therapy and More MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the myelin sheath on specific neurons that suppress excess electric activity in other nerve cells may disrupt cognitive abilities of brain. And reads the column by Ed Tobias, The MS Wire, “MS News That Caught My Eye Last Week: Brain Atrophy, CD25, Neurodynamic Therapy, Anxiety”. ============...
10m Mar 02, 2022
10m
Eating Greens May Reduce MS Risk & Bone Health and More MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how study findings also suggest the chances of developing multiple sclerosis may be higher if you eat more cheese, poultry, sweets, fried foods. Price also reads the column by Ed Tobias, The MS Wire, “MS News That Caught My Eye Last Week: aHSCT, Myelin Vaccine, Bone Health, MIND Diet”. ==========================...
10m Feb 28, 2022
10m
Physical Activity Plus Coping Skills Can Ease Anxiety & Trigeminal Neuralgia and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how lesser feelings of anxiety were reported by MS patients who were more physical active, socially engaged, and made use of coping skills. Price also reads the column by Ed Tobias, MS Wire, “What Is Trigeminal Neuralgia in MS All About, Anyway?”. =================================== Are you interested in learnin...
10m Feb 25, 2022
10m
Jenn Powell Talks to Stuart Schlossman, President of MS Views and News
Stuart Schlossman is an MS patient as well as president and founder of MS Views and News.MS Views and News (MSVN) is a Grassroots, Non-Profit 501C3, Nationally-based MS Patient Advocacy organization which provides educational programs, advocacy and resources to empower and enhance the quality of life, for the MS community. Join Jenn and Stuart as they discuss Stuart’s difficult journey toward a...
45m Feb 24, 2022
45m
Weak Bones May Affect Many With MS & What an MS Patient Carries in a Bag
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a large review study found poorer bone density (osteopenia) in almost half of MS patients evaluated and osteoporosis in about 17%. He also reads “The Big Blue Bag and a ‘Cast Away’ Bed”, a column by John Connor. =================================== Are you interested in learning more about mult...
11m Feb 23, 2022
11m
Endurance Sports Inspire Young Frenchman With RRMS & Slowing Down Is Healthy
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Armand Thoinet. Armand was an active 19-year-old when he was diagnosed with relapsing-remitting MS. Since then, he manages his symptoms through endurance sports and advocacy. Price also reads “Don’t Worry and Take Your Time”, a column by Jamie Hughes. =================================== Are you...
12m Feb 21, 2022
12m
Pasithea to Develop Vaccine to Train Immune System & Participating in MS Clinical Trials
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Pasithea Therapeutics, working with Hooke labs, wants to develop a "tolerizing" vaccine that will train the immune system and protect myelin; and reads the column by John Connor, Fall Down, Get Up Again, “At 64, I’m Surprised to Be Scrambling to Mount a Chariot”. =================================== Are you i...
8m Feb 18, 2022
8m
Self-injectable Therapies Show No Disease Activity in 50% of Patients & Slowing Down Is Healthy
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how over half of MS patients treated with self-injectable therapies showed no evidence of disease activity after two years, a Turkish study found; he also reads “Don’t Worry and Take Your Time”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple scler...
9m Feb 16, 2022
9m
MS Shows Changes In Methylation & How Tyler Campbell Traded Football for MS Advocating
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how multiple sclerosis is characterized by changes in methylation – a type of chemical modification in DNA – in immune cells called T-cells.  Price also reads the article by Hawken Miller, “Tyler Campbell Traded Football Cleats for a Microphone”. =================================== Are you interested in learnin...
16m Feb 14, 2022
16m
COVID Booster May Benefit Patients on Anti-CD20 Therapy & MS Hiker To Attempt Appalachian Trail
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about how MS patients with weak COVID-19 vaccine responses and receiving an anti-CD20 therapy are likely to respond favorably to the booster shot; Price also reads the column by Ed Tobias, MS Wire, “MS Hiker Laces Up Her Boots for Appalachian Trail”. =================================== Are you interested in learning ...
11m Feb 11, 2022
11m
Eating Meat Affects MS via Gut Bacteria & How Art Can Benefit People With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about a study in 24 RRMS patients linked meat consumption with changes to the immune system, gut microbiome, and metabolism relative to controls. Price also reads the column by Jamie Hughes, A Life in Letters, “Art for Our Sake”. =================================== Are you interested in learning mo...
13m Feb 09, 2022
13m
Study Explains How Epstein-Barr Virus Infection Could Cause MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the similarities between an Epstein-Barr (EBV) protein and GlialCAM protein may explain why EBV infection raises the risk of multiple sclerosis. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisne...
10m Feb 07, 2022
10m
Study Shows How Vitamin D Can Influence Immune System
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how vitamin D can influence immune system tolerance to certain proteins by changing how the DNA is packaged in dendritic cells, study reports. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===========...
5m Feb 04, 2022
5m
Mindfulness Helps Manage MS Symptoms & Every Moment Matters With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mindfulness-based interventions helped people with MS cope with symptoms, according to a review of published studies. and also reads the column by Jamie Hughes, A Life in Letters, “No Wasted Moments”. =================================== Are you interested in learning more about multiple sclerosis? If so, ple...
13m Feb 02, 2022
13m
Never Drinking Alcohol Tied to “Significantly” Higher MS Risk” & When MS Takes a Back Seat
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people who do not drink alcohol are at increased risk of developing multiple sclerosis (MS), especially if they also are or were smokers.  Price also reads reads the column by John Connor, Fall Down, Get Up Again, “This Week, MS Takes a Back Seat”. =================================== Are you interested in l...
5m Jan 31, 2022
5m
FDA Approves Cortrophin Gel for MS Flare-Ups & An Epstein-Barr Virus Primer for MS Patients
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the FDA has approved Cortrophin Gel, an ACTH gel first introduced in the 1950s, for treating acute flare-ups in multiple sclerosis (MS); and reads “An Epstein-Barr Virus Primer for MS Patients”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple scle...
8m Jan 28, 2022
8m